[ad_1] Amarin Corporation plc (NASDAQ: AMRN) shares were falling Monday following the presentation of detailed primary results from the the late-stage REDUCE-IT study that evaluated Vascepa, held at a late-breaking session at …
Read More »Single dose of J & J's Stelara shows treatment effect in late-stage advanced cancer study – Johnson & Johnson (NYSE: JNJ)
[ad_1] Results from a Phase 3 clinical trial, UNIFI, on Janssen Pharmaceuticals (NYSE: JNJ) STELARA (ustekinumab) from Johnson & Johnson (NYSE: JNJ) in adult patients with moderate to severe ulcerative colitis who …
Read More »